Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone-Reference-Cited by-同舟云学术

Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone

Published:2022-03-07 Issue:5 Volume:11 Page:576-584
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharm in Drug Dev

Author:

Park Jungsin¹,Kim Choon Ok²,Oh Eun Sil¹,Lee Jung Il³,Kim Ja Kyung⁴,Ahn Sang Hoon⁵,Kim Do Young⁵,Kim Seung Up⁶,Kim Beom Kyung⁶,Chung Yong Eun⁷,Kim Se‐mi⁸,Park Min Soo¹²⁹

Affiliation:

1. Department of Pharmaceutical Medicine and Regulatory Science Colleges of Medicine and Pharmacy Yonsei University Incheon Republic of Korea

2. Department of Clinical Pharmacology Severance Hospital Yonsei University College of Medicine Seoul Republic of Korea

3. Department of Internal Medicine Gangnam Severance Hospital Yonsei University College of Medicine Seoul Republic of Korea

4. Department of Internal Medicine Yongin Severance Hospital Yonsei University College of Medicine Gyeonggi‐do Republic of Korea

5. Department of Internal Medicine Severance Hospital Yonsei University College of Medicine Seoul Republic of Korea

6. Yonsei Liver Centre Severance Hospital Yonsei University College of Medicine Seoul Republic of Korea

7. Department of Radiology Severance Hospital Yonsei University College of Medicine Seoul Republic of Korea

8. Department of Nonclinical Development Chong Kun Dang Research Institute Chong Kun Dang Pharmaceutical Corp., Ltd Seoul Republic of Korea

9. Department of Pediatrics Yonsei University College of Medicine Seoul Republic of Korea

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.1045

Reference26 articles.

1. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040

2. Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease

3. Effects of Liver Disease on Pharmacokinetics

4. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction

5. A Semi-Mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug Clearance

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lobeglitazone and Its Therapeutic Benefits: A Review;Cureus;2023-12-06